Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest pharmaceutical Stories

2014-04-17 16:26:44

SHERBROOKE, Quebec and BIRMINGHAM, Ala., April 17, 2014 /PRNewswire-USNewswire/ -- Cyclenium Pharma Inc., an emerging pharmaceutical company specializing in the research and development of novel drug candidates based on proprietary macrocyclic chemistry, today announced the signing of a discovery and co-development agreement with Southern Research Institute, a not-for-profit 501(c)(3) scientific research organization founded in 1941. The collaboration will utilize Cyclenium's...

2014-04-16 12:29:54

PLYMOUTH MEETING, Pa., April 16, 2014 /PRNewswire/ -- ePharmaSolutions, a leading provider of eClinical solutions announced the results of the initial pilot studies for its patient matching and triaging solution, ReferralPlus(TM), that suggest a significant improvement in match rates for people who are actively searching for clinical trials in which to participate. "We are absolutely thrilled with the results of these pilots and want to thank all of the pharmaceutical companies who helped...

2014-04-16 08:33:00

CHARLESTON, S.C., April 16, 2014 /PRNewswire/ -- Innocutis, a specialty pharmaceutical company in Dermatologic and Podiatric specialties, is pleased to announce that Nuvail [poly-ureaurethane, 16%] is currently the #1 Prescribed Brand for Nail Dystrophy in both dermatology and podiatry. Nail Dystrophy affects a vast portion of the U.S. population and the medical community has had limited treatment options to effectively address this growing problem. Photo -...

2014-04-15 16:28:26

SAN DIEGO, April 15, 2014 /PRNewswire/ -- Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system (CNS) disorders, today announced that the U.S. District Court in Massachusetts entered an order, preventing the implementation of the Commonwealth's ban of Zohydro(TM) ER on Constitutional grounds. This order will become effective on April 22, 2014. The court decision today supports the...

2014-04-15 16:28:23

EMERYVILLE, Calif., April 15, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. (Adamas) (Nasdaq:ADMS), a specialty pharmaceutical company, today announced the closing of its initial public offering of 3,000,000 shares of its common stock at a public offering price of $16.00 per share. The shares began trading on The NASDAQ Global Market under the ticker symbol "ADMS" on April 10, 2014. Adamas estimates net proceeds from the offering to be approximately $41.5 million after deducting...

2014-04-15 08:29:35

OXFORD, England and PITTSBURGH, April 15, 2014 /PRNewswire/ -- Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, today announced that it has entered into a global licensing agreement with Mylan Inc. (Nasdaq: MYL), one of the world's leading global pharmaceutical companies, for its leading inhaled respiratory products, PSX1001 and PSX1050. PSX1001 and PSX1050, which are the first products to emerge from Prosonix's...

2014-04-10 12:25:28

LONDON, April 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Brazil Pharmaceuticals and Healthcare Report Q1 2014 Includes 3 FREE quarterly updatesBMI View:Brazil's traditional commitment to healthcare improvement and growing middle-classpopulation present significant revenue-generating opportunities for multinationals in the country. TheBrazilian pharmaceutical market is now an integral part of all large pharmaceutical companies' strategicoutlook....

2014-04-10 08:29:34

GREENWOOD VILLAGE, Colo., April 10, 2014 /PRNewswire/ -- Ampio Pharmaceuticals Inc. (NYSE MKT: AMPE) today announced that its wholly-owned subsidiary Vyrix Pharmaceuticals, a specialty pharmaceutical company focused on developing and commercializing late-stage prescription pharmaceuticals to improve men's sexual health, has signed an agreement with Paladin Labs Inc., a leading Canadian specialty pharmaceutical company, to provide exclusive rights to market, sell and distribute...

2014-04-10 08:29:24

DUBLIN, Ireland, April 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/g7zq72/pharmaceutical) has announced the addition of the "Pharmaceutical Regulatory Affairs in Africa - Including South Africa (Seminar, London) - 28th & 29th April 2014" [http://www.researchandmarkets.com/research/g7zq72/pharmaceutical ] conference to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The...

2014-04-10 08:29:11

DUBLIN, April 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/fcfbhm/pharmaceutical) has announced the addition of the "Pharmaceutical Regulatory Affairs in the Middle East - Bahrain, Egypt, Iran Iraq Israel, Jordan, Kuwait, Lebanon, Libya, Oman Palestine, Qatar, Saudi Arabia, Sudan Syria, UAE, Yemen (Seminar, London)" [http://www.researchandmarkets.com/research/fcfbhm/pharmaceutical ] conference to their offering. (Logo:...